Rationale and Design of a Randomised Phase II Multicentre Crossover Trial Investigating a Sodium-Glucose Co-Transporter 2 Inhibitor, Dapagliflozin, Combined with a Novel Continuous Ketone Monitor in Adults with Type 1 Diabetes to Reduce the Risk of Diabetic Ketoacidosis: the PARTNER Study
BMJ open(2025)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要